Can TrilliumBiO and Oncobit make MRD monitoring standard for uveal melanoma in the U.S.?

TrilliumBiO and Oncobit launch a ctDNA-based monitoring platform for uveal melanoma in the U.S. Learn how this could change rare cancer care in 2026.

TrilliumBiO and Oncobit launch a ctDNA-based monitoring platform for uveal melanoma in the U.S. Learn how this could change rare cancer care in 2026.

Guardant Health brings its Guardant360 CDx test to Policlinico Gemelli in Italy. Find out how in-house liquid biopsy could reshape cancer diagnostics in Europe.

ProVerum wins FDA approval for ProVee, a permanent urethral stent for BPH offering fast recovery and no catheter. See how it could disrupt the urology device market.

Johnson & Johnson’s CARVYKTI shows 80 percent treatment-free survival at 30 months in second-line myeloma. Is CAR-T moving to earlier use?

Medtronic’s Hugo robot gets FDA clearance for urology. Explore how it could reshape U.S. robotic surgery and challenge incumbent systems like da Vinci.

Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.

Philips unveils AVW 16 and new AI integrations at RSNA 2025. Find out how its cloud-native platform strategy could reshape diagnostic imaging workflows.

Philips expands LumiGuide AI 3D light-based navigation across US and Europe. Find out how it could reshape image-guided therapy without radiation.

Philips launches Verida, the first AI-native detector-based spectral CT. Find out how it could redefine radiology workflows and cardiac diagnostics.

Find out how Philips’ new AI-powered cardiac MR innovations could transform access, speed, and diagnostic precision in cardiovascular imaging.